v3.26.1
Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
April 2026 Canaccord Equity Offering and Warrant Issuance
Common Stock
May 2026 Canaccord Equity Offering and Warrant Issuance
Common Stock
Additional Paid-in Capital
April 2026 Canaccord Equity Offering and Warrant Issuance
Additional Paid-in Capital
May 2026 Canaccord Equity Offering and Warrant Issuance
Additional Paid-in Capital
Accumulated Deficit
April 2026 Canaccord Equity Offering and Warrant Issuance
May 2026 Canaccord Equity Offering and Warrant Issuance
Total
Balance at Dec. 31, 2024     $ 1,414     $ 144,155,694 $ (134,849,462)     $ 9,307,646
Balance, shares at Dec. 31, 2024     14,141,521              
Changes in Stockholders' Equity (Deficit)                    
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs     $ 9     502,925       502,934
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs, shares     94,710              
Issuance of common stock and warrants under registered offering, net of issuance costs     $ 525     19,279,964       19,280,489
Issuance of common stock and warrants under registered offering, net of issuance costs, shares     5,250,000              
Stock-based compensation expense           499,887       499,887
Net loss             (5,537,069)     (5,537,069)
Balance at Mar. 31, 2025     $ 1,948     164,438,470 (140,386,531)     24,053,887
Balance, shares at Mar. 31, 2025     19,486,231              
Balance at Dec. 31, 2024     $ 1,414     144,155,694 (134,849,462)     9,307,646
Balance, shares at Dec. 31, 2024     14,141,521              
Changes in Stockholders' Equity (Deficit)                    
Net loss                   (11,757,127)
Balance at Jun. 30, 2025     $ 1,948     164,935,088 (146,606,589)     18,330,447
Balance, shares at Jun. 30, 2025     19,486,231              
Balance at Mar. 31, 2025     $ 1,948     164,438,470 (140,386,531)     24,053,887
Balance, shares at Mar. 31, 2025     19,486,231              
Changes in Stockholders' Equity (Deficit)                    
Stock-based compensation expense           496,618       496,618
Net loss             (6,220,058)     (6,220,058)
Balance at Jun. 30, 2025     $ 1,948     164,935,088 (146,606,589)     18,330,447
Balance, shares at Jun. 30, 2025     19,486,231              
Balance at Dec. 31, 2025     $ 2,719     180,552,190 (163,703,659)     16,851,250
Balance, shares at Dec. 31, 2025     27,199,139              
Changes in Stockholders' Equity (Deficit)                    
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs     $ 135     3,698,232       3,698,367
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs, shares     1,338,163              
Stock-based compensation expense           182,823       182,823
Net loss             (17,606,382)     (17,606,382)
Balance at Mar. 31, 2026     $ 2,854     184,433,245 (181,310,041)     3,126,058
Balance, shares at Mar. 31, 2026     28,537,302              
Balance at Dec. 31, 2025     $ 2,719     180,552,190 (163,703,659)     $ 16,851,250
Balance, shares at Dec. 31, 2025     27,199,139              
Changes in Stockholders' Equity (Deficit)                    
Exercise of stock options, shares                   71,426
Net loss                   $ (32,427,198)
Balance at Jun. 30, 2026     $ 4,260     191,871,978 (196,130,856)     (4,254,618)
Balance, shares at Jun. 30, 2026     42,606,152              
Balance at Mar. 31, 2026     $ 2,854     184,433,245 (181,310,041)     3,126,058
Balance, shares at Mar. 31, 2026     28,537,302              
Changes in Stockholders' Equity (Deficit)                    
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs     $ 84     1,760,841       1,760,925
Issuance of common stock, pursuant to Equity Distribution Agreement, net of issuance costs, shares     839,268              
Issuance of common stock and warrants under registered underwritten offering, net of issuance costs and warrant liability $ 526 $ 789   $ 2,707,633 $ 1,345,326     $ 2,708,159 $ 1,346,115  
Issuance of common stock and warrants under registered underwritten offering, net of issuance costs and warrant liability, shares 5,263,156 7,895,000                
Exercise of stock options     $ 7     16,278       16,285
Exercise of stock options, shares     71,426              
Stock-based compensation expense           1,608,655       1,608,655
Net loss             (14,820,815)     (14,820,815)
Balance at Jun. 30, 2026     $ 4,260     $ 191,871,978 $ (196,130,856)     $ (4,254,618)
Balance, shares at Jun. 30, 2026     42,606,152